Castresana-Aguirre, Miguel
Johansson, Annelie
Matikas, Alexios
Foukakis, Theodoros
Lindström, Linda S.
Tobin, Nicholas P.
Funding for this research was provided by:
Cancerfonden (21 0277 JCIA 01 H, 222081, 220552SIA, 200802)
Vetenskapsrådet (2020-02466)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2019-00477)
ALF medicine (FoUI-974882)
Gösta Milton Donation Fund
Iris, Stig och Gerry Castenbäcks Stiftelse for cancer research
the King Gustaf V Jubilee Foundation
Karolinska Institute
Article History
Received: 21 June 2023
Accepted: 27 February 2024
First Online: 7 March 2024
Declarations
:
: Publicly available data—Not applicable.
: N.P.T. has performed consultations to Pfizer. A.M. has performed consultations to Veracyte (no financial or any other compensation) and Roche (no financial or any other compensation). T.F. consultancy to Astra Zeneca, Gilead, Affibody, Pfizer, Novartis, Veracyte, Exact Sciences and Roche; honoraria from UpToDate; research funding to institution from Pfizer, Astra Zeneca, Novartis.